Pakistani citizens will soon be able to authenticate pharmaceutical products directly from their mobile phones before making a purchase. The Drug Regulatory Authority of Pakistan (DRAP) has initiated its digitalization process under the Digital Nation Pakistan initiative, introducing a digital medicine verification system designed to curb fake and unregistered drugs across the domestic market. For tech professionals, healthcare workers, and everyday consumers, this system shifts drug verification directly into the hands of the buyer.

How DRAP Scans and Central Database Verification Work

The verification process relies on a direct connection between printed product codes and DRAP's central records. Under the proposed architecture, pharmaceutical manufacturers will print a scan code on the outer packaging of medicine boxes and vials. Consumers can scan this code using their smartphone cameras or a dedicated mobile application.

Once scanned, the mobile request queries DRAP's centralized database in real time. The platform returns specific batch details to the user's screen, including:

  • Manufacturing date and batch identification numbers
  • Official import dates and registered importer details for foreign pharmaceuticals
  • Product expiry dates and batch shelf-life confirmation
  • Regulatory authorization status confirming active DRAP registration

By making these data points available instantly at the point of sale, buyers no longer need to rely on verbal assurances from pharmacy staff or informal supplier networks. Similar to how integrating state databases eliminates fake documentation in other public sectors, centralized database checks create a verifiable digital trail for consumer goods.

Who Benefits from Mobile Medicine Verification

Counterfeit drugs present severe health risks and financial distortion in Pakistan's retail pharmacy sector. Direct mobile verification changes how various stakeholders interact with the pharmaceutical supply chain.

Consumers gain immediate control over their purchases. Rather than checking expiration dates printed on potentially altered cardboard packages, buyers cross-reference physical packaging against live regulatory records.

Registered pharmaceutical manufacturers and authorized importers gain protection against counterfeiters who sell unauthorized copies of commercial drugs. When unverified batches fail code checks at retail outlets, illegitimate stock becomes difficult to distribute.

Regulators gain actionable monitoring points. DRAP previously contacted the Pakistan Telecommunication Authority (PTA) to request blocks on websites selling unregistered and smuggled drugs. Connecting real-time scanning with database logs gives regulatory bodies better visibility over where unverified scans occur across different cities.

Integration with Digital Nation Pakistan and Health Infrastructure

This digital medicine verification system is part of the broader Digital Nation Pakistan framework, which targets digital adoption across government agencies. The digitalization of DRAP aligns with several ongoing national technology programs in public health and trade management.

Within public health, the project complements the proposed One Patient, One ID system designed for universal medical records. Simultaneously, institutions like the Precision Medicine Lab continue to advance local health research data infrastructure.

In pharmaceutical trade, the Pakistan Single Window (PSW) initiative already introduced the digital Certificate of Pharmaceutical Product (CoPP) for exports. This existing export verification system, combined with DRAP's consumer-facing database, builds structured tracking for drugs entering and leaving the country. Similar to how digitally linking institutional systems reduces administrative delays, connected health databases allow rapid validation across government departments.

Implementation Risks Across the Supply Chain

While the digital platform introduces verifiable data access, technical and operational challenges remain for full execution across Pakistan's retail market.

The system's reliability rests entirely on DRAP's database accuracy. If manufacturers fail to update batch entries prior to distribution, legitimate medicine shipments risk being flagged as unverified by retail consumers.

Supply chain adoption across small, non-digitized dispensaries in rural areas presents a physical barrier. Distributors must ensure code integrity remains intact throughout transit, preventing damaged or obscured codes on medicine boxes from blocking customer verification.

Public adoption requires sustained educational outreach. Prime Minister Shehbaz Sharif is expected to inaugurate the system soon. The government plans to launch an awareness campaign alongside the launch to instruct citizens on code-scanning procedures. However, official authorities have not yet announced a firm launch date.

Questions Readers Are Asking About DRAP Digital Verification

Will every medicine in Pakistan have a scan code immediately?

Full implementation across every domestic and imported pharmaceutical product depends on how quickly manufacturers update packaging lines and feed batch records into DRAP's central database. Early rollout focus will likely target key commercial batches.

Do consumers need a specialized app to scan medicine codes?

The system operates by connecting mobile phone cameras or scanning tools to DRAP's web database. Specific application requirements or browser links will be clarified during the official public awareness campaign.

What happens if a scanned medicine shows unverified status?

If a scanned code returns no match or inconsistent batch details, the consumer can spot the discrepancy before payment. The system provides an immediate signal that the item lacks proper regulatory clearance in DRAP's active registry.

Source: PhoneWorld